These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

438 related items for PubMed ID: 20729332

  • 1. Route of antigen uptake differentially impacts presentation by dendritic cells and activated monocytes.
    Kamphorst AO, Guermonprez P, Dudziak D, Nussenzweig MC.
    J Immunol; 2010 Sep 15; 185(6):3426-35. PubMed ID: 20729332
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Selection of an antibody library identifies a pathway to induce immunity by targeting CD36 on steady-state CD8 alpha+ dendritic cells.
    Tagliani E, Guermonprez P, Sepúlveda J, López-Bravo M, Ardavín C, Amigorena S, Benvenuti F, Burrone OR.
    J Immunol; 2008 Mar 01; 180(5):3201-9. PubMed ID: 18292544
    [Abstract] [Full Text] [Related]

  • 5. Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation.
    Singh SK, Stephani J, Schaefer M, Kalay H, García-Vallejo JJ, den Haan J, Saeland E, Sparwasser T, van Kooyk Y.
    Mol Immunol; 2009 Dec 01; 47(2-3):164-74. PubMed ID: 19818504
    [Abstract] [Full Text] [Related]

  • 6. Sustained cross-presentation capacity of murine splenic dendritic cell subsets in vivo.
    Ho NI, Camps MGM, de Haas EFE, Ossendorp F.
    Eur J Immunol; 2018 Jul 01; 48(7):1164-1173. PubMed ID: 29676785
    [Abstract] [Full Text] [Related]

  • 7. Dendritic cells process synthetic long peptides better than whole protein, improving antigen presentation and T-cell activation.
    Rosalia RA, Quakkelaar ED, Redeker A, Khan S, Camps M, Drijfhout JW, Silva AL, Jiskoot W, van Hall T, van Veelen PA, Janssen G, Franken K, Cruz LJ, Tromp A, Oostendorp J, van der Burg SH, Ossendorp F, Melief CJ.
    Eur J Immunol; 2013 Oct 01; 43(10):2554-65. PubMed ID: 23836147
    [Abstract] [Full Text] [Related]

  • 8. CD13 regulates dendritic cell cross-presentation and T cell responses by inhibiting receptor-mediated antigen uptake.
    Ghosh M, McAuliffe B, Subramani J, Basu S, Shapiro LH.
    J Immunol; 2012 Jun 01; 188(11):5489-99. PubMed ID: 22544935
    [Abstract] [Full Text] [Related]

  • 9. Stroma-dependent development of two dendritic-like cell types with distinct antigen presenting capability.
    Periasamy P, O'Neill HC.
    Exp Hematol; 2013 Mar 01; 41(3):281-92. PubMed ID: 23178375
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The C-type lectin receptor CLEC9A mediates antigen uptake and (cross-)presentation by human blood BDCA3+ myeloid dendritic cells.
    Schreibelt G, Klinkenberg LJ, Cruz LJ, Tacken PJ, Tel J, Kreutz M, Adema GJ, Brown GD, Figdor CG, de Vries IJ.
    Blood; 2012 Mar 08; 119(10):2284-92. PubMed ID: 22234694
    [Abstract] [Full Text] [Related]

  • 13. FcRγ-chain ITAM signaling is critically required for cross-presentation of soluble antibody-antigen complexes by dendritic cells.
    Boross P, van Montfoort N, Stapels DA, van der Poel CE, Bertens C, Meeldijk J, Jansen JH, Verbeek JS, Ossendorp F, Wubbolts R, Leusen JH.
    J Immunol; 2014 Dec 01; 193(11):5506-14. PubMed ID: 25355925
    [Abstract] [Full Text] [Related]

  • 14. MHC class I/peptide transfer between dendritic cells overcomes poor cross-presentation by monocyte-derived APCs that engulf dying cells.
    Qu C, Nguyen VA, Merad M, Randolph GJ.
    J Immunol; 2009 Mar 15; 182(6):3650-9. PubMed ID: 19265143
    [Abstract] [Full Text] [Related]

  • 15. The dominant role of CD8+ dendritic cells in cross-presentation is not dictated by antigen capture.
    Schnorrer P, Behrens GM, Wilson NS, Pooley JL, Smith CM, El-Sukkari D, Davey G, Kupresanin F, Li M, Maraskovsky E, Belz GT, Carbone FR, Shortman K, Heath WR, Villadangos JA.
    Proc Natl Acad Sci U S A; 2006 Jul 11; 103(28):10729-34. PubMed ID: 16807294
    [Abstract] [Full Text] [Related]

  • 16. Cutting edge: intravenous soluble antigen is presented to CD4 T cells by CD8- dendritic cells, but cross-presented to CD8 T cells by CD8+ dendritic cells.
    Pooley JL, Heath WR, Shortman K.
    J Immunol; 2001 May 01; 166(9):5327-30. PubMed ID: 11313367
    [Abstract] [Full Text] [Related]

  • 17. Cutting edge: limited specialization of dendritic cell subsets for MHC class II-associated presentation of viral particles.
    Keller SA, Bauer M, Manolova V, Muntwiler S, Saudan P, Bachmann MF.
    J Immunol; 2010 Jan 01; 184(1):26-9. PubMed ID: 19949081
    [Abstract] [Full Text] [Related]

  • 18. Thymic but not splenic CD8⁺ DCs can efficiently cross-prime T cells in the absence of licensing factors.
    Dresch C, Ackermann M, Vogt B, de Andrade Pereira B, Shortman K, Fraefel C.
    Eur J Immunol; 2011 Sep 01; 41(9):2544-55. PubMed ID: 21748731
    [Abstract] [Full Text] [Related]

  • 19. Acquisition of MHC:peptide complexes by dendritic cells contributes to the generation of antiviral CD8+ T cell immunity in vivo.
    Smyth LA, Hervouet C, Hayday T, Becker PD, Ellis R, Lechler RI, Lombardi G, Klavinskis LS.
    J Immunol; 2012 Sep 01; 189(5):2274-82. PubMed ID: 22821960
    [Abstract] [Full Text] [Related]

  • 20. Induction of MHC class I presentation of exogenous antigen by dendritic cells is controlled by CD4+ T cells engaging class II molecules in cholesterol-rich domains.
    Machy P, Serre K, Baillet M, Leserman L.
    J Immunol; 2002 Feb 01; 168(3):1172-80. PubMed ID: 11801652
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.